Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Drug Policy
Showing Original Post only (View all)More research is available on cannabis than many FDA-approved drugs [View all]
There's more research available on cannabis than many FDA-approved drugs
http://www.washingtonpost.com/national/health-science/fda-drug-approvals-based-on-varied-data-study-finds/2014/01/21/b12d0712-82be-11e3-8099-9181471f7aaf_story.html
The Food and Drug Administration must bless any new drugs as safe and effective before they wind up in pharmacy aisles or prescribed to patients. But the ways in which the agency arrives at those approvals vary widely in their thoroughness, according to an analysis by researchers at Yale Universitys School of Medicine.
Not all FDA approvals are created equally, said Nicholas Downing, lead author of the study, which examined nearly 200 new drug approvals between 2005 and 2012.
Researchers found broad differences in the data it took to get a thumbs up from FDA. For instance, the agency required that many new drugs prove themselves in large, high-quality clinical trials. But about a third won approval on the basis of a single clinical trial, and many other trials involved small groups of patients and shorter durations. Only about 40 percent of approvals included trials in which the new drug was compared with existing drugs on the market.
The Food and Drug Administration must bless any new drugs as safe and effective before they wind up in pharmacy aisles or prescribed to patients. But the ways in which the agency arrives at those approvals vary widely in their thoroughness, according to an analysis by researchers at Yale Universitys School of Medicine.
Not all FDA approvals are created equally, said Nicholas Downing, lead author of the study, which examined nearly 200 new drug approvals between 2005 and 2012.
Researchers found broad differences in the data it took to get a thumbs up from FDA. For instance, the agency required that many new drugs prove themselves in large, high-quality clinical trials. But about a third won approval on the basis of a single clinical trial, and many other trials involved small groups of patients and shorter durations. Only about 40 percent of approvals included trials in which the new drug was compared with existing drugs on the market.
For cannabis?
20,000 published studies or reviews in the scientific literature referencing the cannabis plant and its cannabinoids, nearly half of which were published within the last five years, according to a keyword search on PubMed Central, the government repository for peer-reviewed scientific research.
Of these, more than 100 are controlled clinical trials assessing the therapeutic efficacy of cannabinoids for a variety of indications.
A 2006 review of 72 of these trials, conducted between the years 1975 and 2004, identifies ten distinct pathologies for which controlled studies on cannabinoids have been published
In fact, a 2008 meta-analysis published in the Journal of the Canadian Medical Association reported that cannabis-based drugs were associated with virtually no elevated incidences of serious adverse side-effects in over 30 years of investigative use.
http://www.suntimes.com/news/otherviews/24615512-452/pot-holds-no-medical-mysteries.html#.U1nRFK1dXQU
Of these, more than 100 are controlled clinical trials assessing the therapeutic efficacy of cannabinoids for a variety of indications.
A 2006 review of 72 of these trials, conducted between the years 1975 and 2004, identifies ten distinct pathologies for which controlled studies on cannabinoids have been published
In fact, a 2008 meta-analysis published in the Journal of the Canadian Medical Association reported that cannabis-based drugs were associated with virtually no elevated incidences of serious adverse side-effects in over 30 years of investigative use.
http://www.suntimes.com/news/otherviews/24615512-452/pot-holds-no-medical-mysteries.html#.U1nRFK1dXQU
At least 10 nations have made cannabis medicine legal for certain conditions (not a synthetic - whole cannabis plant medicine in the form of Sativex). This has been reality since 2010.
Cannabis has been used by humans for religious, health and recreational purposes for more than 5000 years. It was available to humans long before alcohol - it doesn't require processing, such as fermentation, and the history of humans indicates that cannabis spread throughout the world via the migration of humans - not by nature.
It, not alcohol, remains part of the pharmcopeia - yet alcohol is legal while cannabis is not.
This is nothing more than corruption on the part of lawmakers, and part of the history of the Republican Party's attacks on liberal voters - from its inception, through Nixon targeting "Jews, psychiatrists and hippies" by disregarding the opinion of Nixon's appointed judge to recommend policy on the subject - and the judge recommended decriminalization, fwiw, to the current prison industrial complex with sentencing law and LEO policy meant to target minorities.
There's nothing more to discuss about whether or not cannabis should be legal. It should be.
The issue now is how to get rid of any politician who does not recognize this reality.
11 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
